Open AccessModification of the existing maximum residue level for epoxiconazole in beetroots
Author(s) -
Brancato Alba,
Brocca Daniela,
Carrasco Cabrera Luis,
De Lentdecker Chloe,
Erdos Zoltan,
Ferreira Lucien,
Greco Luna,
Jarrah Samira,
Kardassi Dimitra,
Leuschner Renata,
Lostia Alfonso,
Lythgo Christopher,
Medina Paula,
Miron Ileana,
Molnar Tunde,
Pedersen Ragnor,
Reich Hermine,
Sacchi Angela,
Santos Miguel,
Stanek Alois,
Sturma Juergen,
Tarazona Jose,
Theobald Anne,
Vagenende Benedicte,
VillamarBouza Laura
Publication year - 2018
Publication title -
efsa journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.076
H-Index - 97
ISSN - 1831-4732
DOI - 10.2903/j.efsa.2018.5419
Subject(s) - residue (chemistry) , enforcement , risk assessment , agriculture , business , agricultural science , chemistry , environmental science , economics , management , political science , biochemistry , biology , ecology , law
In accordance with Article 6 of Regulation ( EC ) No 396/2005, the applicant Agriculture & Horticulture Development Board submitted a request to the competent national authority in the United Kingdom to modify the existing maximum residue level ( MRL ) for the active substance epoxiconazole in beetroots. The data submitted in support of the request were found to be sufficient to derive a MRL proposal for beetroots. Adequate analytical methods for enforcement are available to control the residues of epoxiconazole in the commodities under evaluation at the validated limit of quantification ( LOQ ) of 0.01 mg/kg. Based on the risk assessment results, EFSA concluded that the short‐term and long‐term intake of residues resulting from the use of epoxiconazole according to the reported agricultural practice is unlikely to present a risk to consumer health. However, the residue definition for risk assessment was set on a provisional basis, pending the outstanding issues on the overall consumer assessment of the triazole derivative metabolites ( TDM s). The reliable end points, appropriate for use in regulatory risk assessment are presented.